COM:NEWRON
Newron Pharmaceuticals
- Stock
Last Close
7.28
22/11 16:30
Market Cap
136.34M
Beta: -
Volume Today
28.77K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 267K - | 201.50K 24.53% | 70K 65.26% | 21.50K 69.29% | 5K 76.74% | 2.50K 50% | 0.50 - | |||||
average payables | 1.60M - | 1.18M 26.12% | 1.34M 13.55% | 1.81M 34.94% | 2.10M 16.22% | 1.69M 19.83% | 1.78M 5.43% | 1.84M 3.49% | 1.39M 24.54% | 1.71M 22.91% | 1.96M 15.12% | |
average receivables | 4.55M - | 2.73M 40.02% | 972K - | |||||||||
book value per share | 1.83 - | 2.31 25.86% | 2.70 17.26% | 3.39 25.23% | 4.15 22.67% | 3.07 26.02% | 2.06 32.91% | 0.97 53.13% | 0.17 81.98% | -0.79 551.56% | -1.68 113.17% | |
capex per share | -0.01 - | -0.00 73.74% | -0.00 168.95% | -0.00 5.10% | -0.00 22.40% | -0.00 41.07% | -0.00 27.49% | -0.00 31.37% | -0.00 42.86% | -0.00 10.00% | -0.00 38.89% | |
capex to depreciation | -1.95 - | -0.67 65.79% | -0.90 35.21% | -2.18 142.05% | -1.29 40.80% | -0.85 34.11% | -0.25 70.91% | -0.16 35.45% | -0.10 40.12% | -0.09 6.88% | -0.05 38.58% | |
capex to operating cash flow | 0.01 - | 0.00 69.06% | 0.00 126.13% | 0.00 26.11% | 0.01 100.66% | 0.00 66.34% | 0.00 7.53% | 0.00 2.22% | 0.00 22.17% | 0.00 7.14% | 0.00 33.15% | |
capex to revenue | -0.02 - | -0.01 34.20% | -0.03 90.31% | -0.01 60.19% | -0.00 56.87% | -0.01 115.24% | -0.01 27.08% | -0.01 8.14% | -0.00 47.86% | -0.00 14.90% | -0.00 58.88% | |
cash per share | 2.08 - | 2.03 2.38% | 2.98 47.23% | 3.16 6.06% | 3.69 16.51% | 2.46 33.33% | 2.19 10.70% | 1.75 20.21% | 1.94 10.70% | 1.28 34.17% | 0.71 44.68% | |
days of inventory on hand | 408.42 - | 78.05 80.89% | 10.99 85.92% | 0.69 93.70% | ||||||||
days payables outstanding | 1.79K - | 800.40 55.18% | 473.17 40.88% | 274.79 41.93% | 305.67 - | 616.27 101.61% | 1.58K 155.58% | |||||
days sales outstanding | 562.82 - | |||||||||||
debt to assets | 0.05 - | 0.03 35.85% | 0.02 44.21% | 0.01 60.68% | 0.28 - | 0.51 83.71% | 0.85 65.83% | 1.23 43.87% | 1.87 52.47% | |||
debt to equity | 0.07 - | 0.04 45.78% | 0.02 47.34% | 0.01 62.60% | 0.46 - | 1.53 232.88% | 13.87 807.68% | -3.25 123.47% | -1.62 50.26% | |||
dividend yield | ||||||||||||
earnings yield | -0.05 - | -0.04 18.98% | -0.07 94.06% | -0.06 22.19% | -0.03 40.73% | -0.16 382.78% | -0.19 22.76% | -0.59 204.93% | -0.53 9.70% | -0.62 17.01% | -0.17 72.67% | |
enterprise value | 140.44M - | 258.66M 84.18% | 286.54M 10.78% | 233.63M 18.47% | 105.28M 54.94% | 67.64M 35.76% | 99.13M 46.56% | 48.67M 50.90% | 45.99M 5.51% | 60.26M 31.02% | 137.18M 127.64% | |
enterprise value over ebitda | -18.15 - | -23.13 27.44% | -12.07 47.83% | -15.53 28.73% | -20.37 31.13% | -4.53 77.74% | -5.11 12.79% | -2.84 44.54% | -3.91 37.92% | -4.52 15.62% | -11.59 156.34% | |
ev to operating cash flow | -13.14 - | -25.87 96.85% | -22.28 13.89% | -11.93 46.45% | -12.53 5.00% | -4.20 66.48% | -4.46 6.30% | -3.12 30.04% | -4.02 28.70% | -5.43 35.19% | -13.53 149.01% | |
ev to sales | 39.68 - | 166.13 318.63% | 120.39 27.53% | 34.74 71.15% | 7.84 77.43% | 16.80 114.33% | 14.08 16.18% | 9.26 34.28% | 7.98 13.77% | 9.89 23.88% | 15.15 53.16% | |
free cash flow per share | -0.94 - | -0.79 15.54% | -0.94 19.26% | -1.34 42.06% | -0.52 61.19% | -0.90 74.24% | -1.25 37.85% | -0.88 29.82% | -0.64 26.61% | -0.62 3.10% | -0.57 8.63% | |
free cash flow yield | -0.07 - | -0.04 46.96% | -0.04 10.77% | -0.07 77.17% | -0.05 26.36% | -0.17 223.50% | -0.21 25.91% | -0.44 105.94% | -0.41 6.62% | -0.40 3.41% | -0.11 73.08% | |
graham net net | 1.53 - | 1.41 7.52% | 2.45 73.57% | 2.70 9.91% | 3.36 24.57% | 2.18 35.02% | 0.88 59.78% | -0.15 117.24% | -0.72 373.17% | -1.59 122.53% | -2.42 51.75% | |
graham number | 5.04 - | 6.43 27.43% | 10.06 56.53% | 8.89 11.61% | 5.50 38.10% | 7.63 38.69% | 7.25 5.04% | 5.06 30.21% | 1.81 64.24% | 4.16 130.24% | 5.86 40.61% | |
income quality | 1.39 - | 0.93 32.70% | 0.51 44.78% | 1.29 150.18% | 1.59 23.09% | 1.07 32.35% | 1.10 2.71% | 0.79 27.87% | 0.77 3.23% | 0.63 17.44% | 0.63 1.40% | |
intangibles to total assets | 0.29 - | 0.19 34.64% | 0.01 96.83% | 0.00 22.76% | 0.00 89.61% | 0.00 4.79% | 0.00 33.95% | 0.00 35.23% | 0.00 81.56% | 0 100% | 0 | |
interest coverage | 123.43 - | 22.79 81.53% | -20.91 191.72% | -116.10 455.27% | -51.13 55.96% | -267.46 423.11% | -36.54 86.34% | -8.07 77.92% | -4.23 47.52% | -3.37 20.42% | -2.79 17.21% | |
interest debt per share | 0.12 - | 0.05 60.94% | 0.14 194.13% | 0.03 75.52% | 0.01 84.56% | 0.00 39.82% | 0.98 31,075.04% | 1.60 63.72% | 2.58 60.93% | 2.78 7.85% | 2.95 5.99% | |
inventory turnover | 0.89 - | 4.68 423.28% | 33.21 610.16% | 526.80 1,486.24% | ||||||||
invested capital | 0.07 - | 0.04 45.78% | 0.02 47.34% | 0.01 62.60% | 0.46 - | 1.53 232.88% | 13.87 807.68% | -3.25 123.47% | -1.62 50.26% | |||
market cap | 157.42M - | 276.33M 75.54% | 321.82M 16.46% | 276.21M 14.17% | 161.56M 41.51% | 95.26M 41.04% | 104.29M 9.48% | 35.54M 65.92% | 27.93M 21.41% | 28.02M 0.33% | 95.10M 239.36% | |
net current asset value | 11.27M - | 21.57M 91.45% | 36.71M 70.13% | 49.30M 34.30% | 67.50M 36.92% | 54.63M 19.07% | 36.46M 33.26% | 3.92M 89.24% | -7.95M 302.75% | -22.73M 185.87% | -36.12M 58.90% | |
net debt to ebitda | 2.19 - | 1.58 28.01% | 1.49 5.96% | 2.83 90.55% | 10.89 284.64% | 1.85 83.00% | 0.27 85.61% | -0.77 387.19% | -1.54 100.75% | -2.42 57.51% | -3.56 46.98% | |
net income per share | -0.62 - | -0.80 29.02% | -1.66 108.95% | -1.04 37.61% | -0.32 68.76% | -0.84 160.02% | -1.13 34.39% | -1.18 3.91% | -0.84 29.04% | -0.98 17.39% | -0.91 7.25% | |
operating cash flow per share | -0.93 - | -0.79 15.13% | -0.94 18.93% | -1.33 42.24% | -0.52 61.33% | -0.90 75.09% | -1.24 37.87% | -0.87 29.82% | -0.64 26.58% | -0.62 3.08% | -0.57 8.58% | |
payables turnover | 0.20 - | 0.46 123.10% | 0.77 69.16% | 1.33 72.19% | 1.19 - | 0.59 50.40% | 0.23 60.87% | |||||
receivables turnover | 0.65 - | |||||||||||
research and ddevelopement to revenue | 1.28 - | 3.86 201.44% | 7.75 100.59% | 1.84 76.22% | 0.64 65.27% | 1.23 91.57% | 1.71 39.15% | 1.97 15.40% | 1.86 5.48% | 1.97 5.84% | 1.45 26.29% | |
return on tangible assets | -0.32 - | -0.34 6.35% | -0.52 54.11% | -0.27 47.70% | -0.07 73.25% | -0.25 248.00% | -0.34 33.14% | -0.41 22.35% | -0.30 28.05% | -0.47 59.34% | -0.63 33.37% | |
revenue per share | 0.31 - | 0.12 60.09% | 0.17 41.32% | 0.46 164.02% | 0.82 79.90% | 0.23 72.62% | 0.39 74.85% | 0.29 25.29% | 0.32 9.59% | 0.34 5.76% | 0.51 48.62% | |
roe | -0.34 - | -0.34 2.51% | -0.61 78.20% | -0.31 50.18% | -0.08 74.54% | -0.27 251.48% | -0.55 100.31% | -1.22 121.72% | -4.80 293.90% | 1.25 126.00% | 0.54 56.49% | |
roic | -0.32 - | -0.35 9.56% | -0.59 69.28% | -0.31 47.96% | -0.06 79.14% | -0.27 327.54% | -0.39 42.34% | -0.44 12.26% | -0.26 39.40% | -0.41 56.57% | -0.62 48.72% | |
sales general and administrative to revenue | 1.07 - | 2.32 116.62% | 1.80 22.30% | 0.68 62.17% | 0.29 56.81% | 1.28 334.48% | 0.91 28.75% | 0.94 2.76% | 0.61 35.32% | 0.58 4.28% | 0.44 24.23% | |
shareholders equity per share | 1.83 - | 2.31 25.86% | 2.70 17.26% | 3.39 25.23% | 4.15 22.67% | 3.07 26.02% | 2.06 32.91% | 0.97 53.13% | 0.17 81.98% | -0.79 551.56% | -1.68 113.17% | |
stock based compensation to revenue | 0.24 - | 0.79 235.62% | 0.95 19.72% | 0.34 64.08% | 0.13 61.88% | 0.52 304.21% | 0.30 42.29% | 0.28 8.02% | 0.13 52.41% | 0.08 40.44% | 0.02 72.39% | |
tangible asset value | 11.96M - | 22.27M 86.11% | 36.85M 65.47% | 49.49M 34.30% | 67.69M 36.78% | 54.81M 19.02% | 36.78M 32.90% | 17.23M 53.14% | 3.10M 81.98% | -14.03M 551.85% | -29.91M 113.17% | |
tangible book value per share | 1.04 - | 1.76 68.83% | 2.69 52.98% | 3.37 25.47% | 4.15 23.25% | 3.07 26.02% | 2.06 32.87% | 0.97 53.13% | 0.17 81.98% | -0.79 551.56% | -1.68 113.17% | |
working capital | 15.73M - | 24.90M 58.32% | 37.46M 50.45% | 49.49M 32.12% | 68.07M 37.54% | 55.23M 18.87% | 54.35M 1.59% | 30.98M 43.00% | 35.77M 15.46% | 23.45M 34.44% | -9.27M 139.54% |
All numbers in (except ratios and percentages)